Cargando…

Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon

INTRODUCTION: The World Health Organization (WHO) recommends that in malaria endemic areas with moderate to high transmission rates, pregnant women presenting for antenatal clinic (ANC) should receive at least three doses of intermittent preventive treatment in pregnancy (IPTp) for malaria between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Diengou, Ngwene Hycentha, Cumber, Samuel Nambile, Nkfusai, Claude Ngwayu, Mbinyui, Mbuh Salioh, Viyoff, Vecheusi Zennobia, Bede, Fala, Akwah, Lilian, Tsoka-Gwegweni, Joyce Mahlako, Judith, Anchang-Kimbi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245972/
https://www.ncbi.nlm.nih.gov/pubmed/32499857
http://dx.doi.org/10.11604/pamj.2020.35.42.17600
_version_ 1783537857001947136
author Diengou, Ngwene Hycentha
Cumber, Samuel Nambile
Nkfusai, Claude Ngwayu
Mbinyui, Mbuh Salioh
Viyoff, Vecheusi Zennobia
Bede, Fala
Akwah, Lilian
Tsoka-Gwegweni, Joyce Mahlako
Judith, Anchang-Kimbi
author_facet Diengou, Ngwene Hycentha
Cumber, Samuel Nambile
Nkfusai, Claude Ngwayu
Mbinyui, Mbuh Salioh
Viyoff, Vecheusi Zennobia
Bede, Fala
Akwah, Lilian
Tsoka-Gwegweni, Joyce Mahlako
Judith, Anchang-Kimbi
author_sort Diengou, Ngwene Hycentha
collection PubMed
description INTRODUCTION: The World Health Organization (WHO) recommends that in malaria endemic areas with moderate to high transmission rates, pregnant women presenting for antenatal clinic (ANC) should receive at least three doses of intermittent preventive treatment in pregnancy (IPTp) for malaria between the 16(th) and 36(th) weeks of pregnancy at intervals of 4 weeks between doses. Several challenges remain in effective implementation of IPTp policy making the targeted coverage (80%) of the third doses of IPTp far from being achieved. The main objective of this study was to assess factors associated with the uptake of IPTp among pregnant women attending ANCs in the Bamenda Health District. METHODS: To reach our objectives, we carried out a cross-sectional study following informed consent with thirty-nine (39) healthcare workers (HCW) and four hundred (400) pregnant women who were either in the third trimester of pregnancy or had recently given birth in any of thirty-six (36) health facilities (HF) within the Bamenda Health District (BHD) from May to August 2014. All sites within the BHD were included. The participants were selected by simple random sampling. The principal research instrument was a structured and pre-tested questionnaire that was designed to capture socio-demographic data and data related to stage of pregnancy and knowledge about IPTp. Data was entered using Ms Excel and analysed using SPSS v20.0. Descriptive statistics (frequencies and percentages) was used to report findings. We used Chi-Square test to compare the categorical variables (Fischer’s exact test was used in cases were conditions for Chi-Square test were not met). RESULTS: Uptake for at least one dose of IPTp was 95.3% (381/400) and 54.9% (209/400) had received all three doses, 15.5% (59/400) received only one dose and 4.8% (19/400) did not receive any of the doses of IPTp. Knowledge about IPTp was associated with an increase uptake of IPTp (P<0.001). All health care providers were knowledgeable about the importance and use of IPTp. However, 35.9% reported not receiving any training on IPTp. Among the health providers, 28.2% did not know when to start IPTp and 43.59% did not know when to stop IPTp. Out of all the health care providers, 30.77% complained of medication (sulfadoxine-Pyrimethamine) stock out and 84.62% practiced the policy of direct observed therapy. CONCLUSION: The uptake of the third dose of IPTp is poor in the Bamenda Health District and this may be attributed to medication stock out and inadequacy of routine trainings for the health providers. The good practice observed was that of direct observed therapy by HCWs. Patient knowledge about IPTp in our study was associated with better uptake of IPTp. Encouraging education of pregnant women on the importance of IPTp, providing routine training to HCWs and promoting direct observation of therapy may improve on IPTp uptake during pregnancy.
format Online
Article
Text
id pubmed-7245972
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-72459722020-06-03 Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon Diengou, Ngwene Hycentha Cumber, Samuel Nambile Nkfusai, Claude Ngwayu Mbinyui, Mbuh Salioh Viyoff, Vecheusi Zennobia Bede, Fala Akwah, Lilian Tsoka-Gwegweni, Joyce Mahlako Judith, Anchang-Kimbi Pan Afr Med J Research INTRODUCTION: The World Health Organization (WHO) recommends that in malaria endemic areas with moderate to high transmission rates, pregnant women presenting for antenatal clinic (ANC) should receive at least three doses of intermittent preventive treatment in pregnancy (IPTp) for malaria between the 16(th) and 36(th) weeks of pregnancy at intervals of 4 weeks between doses. Several challenges remain in effective implementation of IPTp policy making the targeted coverage (80%) of the third doses of IPTp far from being achieved. The main objective of this study was to assess factors associated with the uptake of IPTp among pregnant women attending ANCs in the Bamenda Health District. METHODS: To reach our objectives, we carried out a cross-sectional study following informed consent with thirty-nine (39) healthcare workers (HCW) and four hundred (400) pregnant women who were either in the third trimester of pregnancy or had recently given birth in any of thirty-six (36) health facilities (HF) within the Bamenda Health District (BHD) from May to August 2014. All sites within the BHD were included. The participants were selected by simple random sampling. The principal research instrument was a structured and pre-tested questionnaire that was designed to capture socio-demographic data and data related to stage of pregnancy and knowledge about IPTp. Data was entered using Ms Excel and analysed using SPSS v20.0. Descriptive statistics (frequencies and percentages) was used to report findings. We used Chi-Square test to compare the categorical variables (Fischer’s exact test was used in cases were conditions for Chi-Square test were not met). RESULTS: Uptake for at least one dose of IPTp was 95.3% (381/400) and 54.9% (209/400) had received all three doses, 15.5% (59/400) received only one dose and 4.8% (19/400) did not receive any of the doses of IPTp. Knowledge about IPTp was associated with an increase uptake of IPTp (P<0.001). All health care providers were knowledgeable about the importance and use of IPTp. However, 35.9% reported not receiving any training on IPTp. Among the health providers, 28.2% did not know when to start IPTp and 43.59% did not know when to stop IPTp. Out of all the health care providers, 30.77% complained of medication (sulfadoxine-Pyrimethamine) stock out and 84.62% practiced the policy of direct observed therapy. CONCLUSION: The uptake of the third dose of IPTp is poor in the Bamenda Health District and this may be attributed to medication stock out and inadequacy of routine trainings for the health providers. The good practice observed was that of direct observed therapy by HCWs. Patient knowledge about IPTp in our study was associated with better uptake of IPTp. Encouraging education of pregnant women on the importance of IPTp, providing routine training to HCWs and promoting direct observation of therapy may improve on IPTp uptake during pregnancy. The African Field Epidemiology Network 2020-02-12 /pmc/articles/PMC7245972/ /pubmed/32499857 http://dx.doi.org/10.11604/pamj.2020.35.42.17600 Text en © Ngwene Hycentha Diengou et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Diengou, Ngwene Hycentha
Cumber, Samuel Nambile
Nkfusai, Claude Ngwayu
Mbinyui, Mbuh Salioh
Viyoff, Vecheusi Zennobia
Bede, Fala
Akwah, Lilian
Tsoka-Gwegweni, Joyce Mahlako
Judith, Anchang-Kimbi
Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title_full Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title_fullStr Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title_full_unstemmed Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title_short Factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the Bamenda health districts, Cameroon
title_sort factors associated with the uptake of intermittent preventive treatment of malaria in pregnancy in the bamenda health districts, cameroon
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245972/
https://www.ncbi.nlm.nih.gov/pubmed/32499857
http://dx.doi.org/10.11604/pamj.2020.35.42.17600
work_keys_str_mv AT diengoungwenehycentha factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT cumbersamuelnambile factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT nkfusaiclaudengwayu factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT mbinyuimbuhsalioh factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT viyoffvecheusizennobia factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT bedefala factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT akwahlilian factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT tsokagwegwenijoycemahlako factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon
AT judithanchangkimbi factorsassociatedwiththeuptakeofintermittentpreventivetreatmentofmalariainpregnancyinthebamendahealthdistrictscameroon